AVORO CAPITAL ADVISORS LLC 13D/13G Filings for Kura Oncology, Inc. (KURA)

AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Kura Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-14
09:32 am
Sale		2022-12-3113GKura Oncology, Inc.
KURA		AVORO CAPITAL ADVISORS LLC3,105,000
4.500%		-895,000decrease
(-22.38%)		Filing
2021-02-12
08:09 am
Purchase		2020-12-3113GKura Oncology, Inc.
KURA		AVORO CAPITAL ADVISORS LLC4,000,000
6.200%		4,000,000increase
(New Position)		Filing